New Search
If you are not happy with the results below please do another search
ENTERPRISE THERAPEUTICS
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. The company is based in the UK with offices at the Sussex Innovation Centre.
Latest News
- TMEM16A Channel Function Does Not Influence Goblet Cell Numbers or Mucin Secretion In The Human Airway Epithelium – NACFC – Nashville – October 2019November 7, 2019 - 5:32 pm
- EACT Increases Intracellular Calcium Levels by a Tmem16a-Independent Mechanism – NACFC – Nashville – October 2019November 7, 2019 - 5:30 pm
- The In Vitro & In Vivo Pharmacology of Novel Tmem16a Potentiator Compounds – NACFC – Nashville – October 2019November 7, 2019 - 5:29 pm
- Enterprise Therapeutics awarded up to £5.7M ($7M) from Cystic Fibrosis Foundation to Support Clinical Development of Novel Chloride Channel ModulatorOctober 15, 2019 - 9:00 am
Follow Us On Twitter
Dr. Henry Danahay, Head of Biology, recently spoke at #NACFC about enhancing the activity of #TMEM16A with low molecular weight, drug-like compounds. If you missed his presentation, visit our website to read more about it: http://bit.ly/32z8geD #respiratory #CF
Contact Us
Sussex Innovation Centre,
University of Sussex,
Science Park Square,
Falmer, Brighton, BN1 9SB
info@enterprisetherapeutics.com
+44 (0)1273 234667
